25 January 2016 - Shire resubmitted the NDA in response to the complete response letter the company received from the FDA on October 16, 2015.

For more detail, go to: https://www.shire.com/newsroom/2016/january/shire-resubmits-new-drug-application-for-lifitegrast-to-us-fda